Relapsed and Refractory CD5 Hematological Tumors
1 clinical trials · Condition
◉ Watch Relapsed and Refractory CD5 Hematological Tumors
| Record | Firm | Date |
|---|---|---|
| CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors (NCT07234110) | Institute of Hematology & Blood Diseases Hospital, China | 2025-09-03 |
Track Relapsed and Refractory CD5 Hematological Tumors automatically
Every clearance here is in the API, with alerts when new ones post.